IBDEI1FG ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,312,0)
 ;;=PARING/CUTTING^16^36
 ;;^UTILITY(U,$J,358.4,313,0)
 ;;=EXCISE BENIGN-SCALP/NECK/HAND/GENITAL/FT^5^36
 ;;^UTILITY(U,$J,358.4,314,0)
 ;;=EXCISE BENIGN-FACE/EAR/NOSE/LIP/LID^4^36
 ;;^UTILITY(U,$J,358.4,315,0)
 ;;=EXCISION BENIGN-TRUNK/ARM/LEG^6^36
 ;;^UTILITY(U,$J,358.4,316,0)
 ;;=EXCISE MALIG-FACE/EAR/NOSE/LIP/LID^7^36
 ;;^UTILITY(U,$J,358.4,317,0)
 ;;=EXCISE MALIG-SCALP/NECK/HAND/GENITAL/FT^8^36
 ;;^UTILITY(U,$J,358.4,318,0)
 ;;=EXCISION MALIG-TRUNK/ARM/LEG^9^36
 ;;^UTILITY(U,$J,358.4,319,0)
 ;;=REPAIR,SIMPLE-SCALP/NECK/TRUNK/EXTREM^21^36
 ;;^UTILITY(U,$J,358.4,320,0)
 ;;=REPAIR,SIMPLE-FACE/EAR/NOSE/LID/LIP^20^36
 ;;^UTILITY(U,$J,358.4,321,0)
 ;;=REPAIR,INTERMED-SCALP/TRUNK/LEG/ARM^19^36
 ;;^UTILITY(U,$J,358.4,322,0)
 ;;=REPAIR,INTERMED-FACE/EAR/NOSE/LID/LIP^17^36
 ;;^UTILITY(U,$J,358.4,323,0)
 ;;=REPAIR,INTERMED-NECK/HAND/GENITAL/FT^18^36
 ;;^UTILITY(U,$J,358.4,324,0)
 ;;=REPAIR-SIMPLE WOUND DEHISCENCE^22^36
 ;;^UTILITY(U,$J,358.4,325,0)
 ;;=NURSING PROCEDURES^14^36
 ;;^UTILITY(U,$J,358.4,326,0)
 ;;=BLOOD^2^36
 ;;^UTILITY(U,$J,358.4,327,0)
 ;;=IV INFUSION^11^36
 ;;^UTILITY(U,$J,358.4,328,0)
 ;;=MEDICATION^12^36
 ;;^UTILITY(U,$J,358.4,329,0)
 ;;=MEDICATION ADMINISTATION^13^36
 ;;^UTILITY(U,$J,358.4,330,0)
 ;;=PARACENTESIS^15^36
 ;;^UTILITY(U,$J,358.4,331,0)
 ;;=OTHER^23^36
 ;;^UTILITY(U,$J,358.4,332,0)
 ;;=POST-OP COMPLICATIONS^16^37
 ;;^UTILITY(U,$J,358.4,333,0)
 ;;=GENERAL/SIGNS & SYMPTOMS^6^37
 ;;^UTILITY(U,$J,358.4,334,0)
 ;;=GYN/BREAST^8^37
 ;;^UTILITY(U,$J,358.4,335,0)
 ;;=MALE BREAST^10^37
 ;;^UTILITY(U,$J,358.4,336,0)
 ;;=BENIGN LESIONS OF SKIN^3^37
 ;;^UTILITY(U,$J,358.4,337,0)
 ;;=MALIGNANT LESIONS OF SKIN^11^37
 ;;^UTILITY(U,$J,358.4,338,0)
 ;;=MELANOMA^12^37
 ;;^UTILITY(U,$J,358.4,339,0)
 ;;=LACERATIONS^9^37
 ;;^UTILITY(U,$J,358.4,340,0)
 ;;=MERKEL CELL CANCER^13^37
 ;;^UTILITY(U,$J,358.4,341,0)
 ;;=AFTERCARE POST SURGERY^2^37
 ;;^UTILITY(U,$J,358.4,342,0)
 ;;=CARDIOVASCULAR^4^37
 ;;^UTILITY(U,$J,358.4,343,0)
 ;;=ENT^5^37
 ;;^UTILITY(U,$J,358.4,344,0)
 ;;=ABDOMINAL PAIN^1^37
 ;;^UTILITY(U,$J,358.4,345,0)
 ;;=GI^7^37
 ;;^UTILITY(U,$J,358.4,346,0)
 ;;=RESPIRATORY^17^37
 ;;^UTILITY(U,$J,358.4,347,0)
 ;;=ORTHOPEDIC^14^37
 ;;^UTILITY(U,$J,358.4,348,0)
 ;;=PLASTIC SURGERY^15^37
 ;;^UTILITY(U,$J,358.4,349,0)
 ;;=UROLOGY^18^37
 ;;^UTILITY(U,$J,358.4,350,0)
 ;;=NEW PATIENT^2^38
 ;;^UTILITY(U,$J,358.4,351,0)
 ;;=ESTABLISHED PATIENT^1^38
 ;;^UTILITY(U,$J,358.4,352,0)
 ;;=CONSULTATIONS^3^38
 ;;^UTILITY(U,$J,358.4,353,0)
 ;;=POST-OP FOLLOW-UP^4^38
 ;;^UTILITY(U,$J,358.4,354,0)
 ;;=ABRASION w/o INFECTION^1^39
 ;;^UTILITY(U,$J,358.4,355,0)
 ;;=ABRASION w/ INFECTION^2^39
 ;;^UTILITY(U,$J,358.4,356,0)
 ;;=ABSCESS/CELLULITIS^3^39
 ;;^UTILITY(U,$J,358.4,357,0)
 ;;=ACNE^4^39
 ;;^UTILITY(U,$J,358.4,358,0)
 ;;=ALOPEICA^5^39
 ;;^UTILITY(U,$J,358.4,359,0)
 ;;=BURNS^6^39
 ;;^UTILITY(U,$J,358.4,360,0)
 ;;=CANDIDIASIS^7^39
 ;;^UTILITY(U,$J,358.4,361,0)
 ;;=CELLULITIS^8^39
 ;;^UTILITY(U,$J,358.4,362,0)
 ;;=DERMATITIS^9^39
 ;;^UTILITY(U,$J,358.4,363,0)
 ;;=DERMATOPHYTOSIS^10^39
 ;;^UTILITY(U,$J,358.4,364,0)
 ;;=ECZEMA^11^39
 ;;^UTILITY(U,$J,358.4,365,0)
 ;;=EDEMA^12^39
 ;;^UTILITY(U,$J,358.4,366,0)
 ;;=ERYTHEMA^13^39
 ;;^UTILITY(U,$J,358.4,367,0)
 ;;=EXPOSURE TO HEALTH HAZARDS^14^39
 ;;^UTILITY(U,$J,358.4,368,0)
 ;;=FOLLICULITIS^15^39
 ;;^UTILITY(U,$J,358.4,369,0)
 ;;=FURUNCLE^16^39
 ;;^UTILITY(U,$J,358.4,370,0)
 ;;=GRANULOMA^17^39
 ;;^UTILITY(U,$J,358.4,371,0)
 ;;=HERPES^35^39
 ;;^UTILITY(U,$J,358.4,372,0)
 ;;=HISTORY^36^39
 ;;^UTILITY(U,$J,358.4,373,0)
 ;;=ICHTHYOSIS^38^39
 ;;^UTILITY(U,$J,358.4,374,0)
 ;;=INSECT BITE w/o INFECTION^39^39
